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ABSTRACT: 
Objective: To assess the antidiabetic and hypolipidemic properties of Stereospermum colais Fruit. 
Methods: Acute toxicity test was done to check the toxicity of Stereospermum colais fruit methanol extract at three dose levels 
was administered orally to streptozotocin (STZ) (40 mg/kg bw) induced diabetic rats for 15 days. The various parameters were 
studied including body weight, fasting blood glucose levels, plasma insulin, lipid profile, glycogen content, glycoslylated 
hemoglobin (HbA1c) and serum marker enzymes levels in normal, treated and diabetic rats. Histochemical analysis of pancreas 
was also carried out in normal treated and diabetic rats.   
Results: The treatment group with the extract at three dose levels showed a significant increase in the liver, muscle glycogen and 
serum insulin level and a significant decrease in fasting blood glucose, glycosylated hemoglobin levels and serum marker enzyme 
levels. The total cholesterol and serum triglycerides levels were also significantly reduced and the high density lipoprotein level 
was significantly increased upon treatment with the Stereospermum colais Fruit methanol extract. Histochemical study of pancreas 
also confirmed the biochemical findings. Acute toxicity studies revealed the non-toxic nature of the Stereospermum colais Fruit 
methanol extract.  Conclusions: The results of the experiments presented here suggest that methanol extract of Stereospermum 
colais Fruit exerts significant antidiabetic and hypolipidaemic effect in STZ induced diabetic rats. 
Keywords: Stereospermum colais, Antidiabetic, Hypolipidemic, Fruit, streptozotocin.  
 
INTRODUCTION: 
Diabetes mellitus (DM) has been defined as a chronic 
disease with persistently elevated blood glucose 
concentration, leading to acute r long term 
complications 
1
. Globally, DM presents enormous and 
increasingly important public health issues. The 
prevalence of DM in all age groups was estimated to be 
2.8% (170 million) in 2000 and the rate is expected to 
rise to 4.4% (366 million) in 2030
2
. The 
pharmacological agents currently used for treatment of 
type 2 diabetes include sulfonylureas, biguanide, 
thiazolidinedione and alpha glycosidase inhibitors. 
These agents, however, have restricted usage due to 
several undesirable side effects and fail to significantly 
alter the course of diabetic complications. Renewed 
attention to alternative medicines and natural therapies 
has stimulated new waves of research interest in 
traditional practices, and there is a need to look for 
more efficacious agents with lesser side effects. 
Presently, there is growing interest in herbal remedies 
due to the side effects associated with oral 




Stereospermum colais (Buch.-Ham.ex Dillw.) is 
commonly known as Mabberley, belonging to the 
family of Bignoniaceae. It is normally found in India, 
Myanmar, and Sri Lanka; in the Western Ghats- South, 
Central and south Maharashtra Sahyadris. In spite of its 
many uses (diarrhoea, cough, asthma, hiccough, 
bleedings, hyperacidity, vomiting, fever, general 
debility, rheumatism, malarial fever, wounds, burning 
sensation, heart disease), the antidiabetic, 
antiperoxidative and radical scavenging activities of 
this species have not been assessed, and its chemical 
composition is scarcely known
5, 6
. 
However, there are no reports on the antidiabetic 
activity of the plant. Hence this study was undertaken 
to evaluate the anti-diabetic activity of methanol 
extract of Stereospermum colais Fruit in sterptozotocin 
(STZ) induced diabetic rats. 
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MATERIALS AND METHODS: 
Plant material:  
The Fruits of Stereospermum Colais were collected 
from Pathnur Ghat, Taluka Ardhapur, District Nanded, 
Maharashtra, India. Plant materials were authenticated 
from Dr. Arvind S Dhabe Dr, Babasaheb Ambedkar 
Marathwada University, Aurangabad. Collected plant 
material was dried in tray dryer at 55
o
C for 24 h and 
powdered. Herbarium was prepared according to 
International curatorial practices. Specimen was given 
a number by the plant identifying authority is 0780 
(reference number Bet/2010-11). 
Preparation of extracts: 
The whole plant of Stereospermum colais Fruit was 
washed thoroughly with water to remove the soil 
particles, and then was air dried and powdered. One 
kilogram of plant material was extracted with methanol 
solvent (2.5 L for each time). The filtrate was 
concentrated under reduced pressure at 40 
o
C and the 
extract was stored in a refrigerator at 4 
o
C for use in 
subsequent experiments. 
Chemicals: 
Sterptozotocin was obtained from Hetero Drugs, 
Hyderabad, India. Kits to estimate total cholesterol, 
triglycerides and HDL-cholesterol kit was purchased 
from Merck, Mumbai, India. All other chemicals were 
of analytical grade. 
Preliminary phytochemical screening of the extract: 
The preliminary phytochemical analysis was carried 
out for the Stereospermum colais Fruit methanol 





Healthy adult Wister albino rats with body weight 
around (170±5) g at 60-70 days from birth and raised 
in the animal house at Oriental College of pharmacy, 
Navi Mumbai were used for the study. Housed 
individually in polypropylene cages, maintained under 
standard conditions in 12 h light and 12 h dark cyle at 
(25±3) 
o
C, the rats were fed with standard rat pellet diet 
(Pranav Agro Industry Ltd., Maharashtra) and water. 
The study was approved by the animal ethical 
committee of the institute (1185/A/08/CPCSEA). 
Acute toxicity study: 
Healthy adult Wister albino rats of either sex starved 
overnight were divided into five groups (n=6) and were 
orally fed with the SC methanol extract in increasing 
dose levels of 100 mg/kg bw, 500 mg/kg bw, 1 g/kg 
bw, 3 g/kg bw and 5 g/kg bw
8
. The animals were 
observed continuously for 2 h under the following 
profiles
9
 (a) Behavioral profile: Alertness, restlessness, 
irritability and fearfulness; (b) Neurological profile: 
spontaneous activity, reactivity, touch response, pain 
response and gait; (c) Autonomic profile: defecation 
and urination. After a period of 24 and 72 h they were 
observed for any lethality or death. 
Oral glucose tolerance test (OGTT): 
The oral glucose tolerance test was performed in 
overnight (18 h) fasted normal rats
10
. Rats divided into 
three groups (n=6) were administered drinking water, 
SC methanol extract at 50, 100, and 200 mg/kg, 
respectively. Glucose (2 g/kg) was fed 30 min after the 
administration of extracts. Blood was withdrawn from 
the retro orbital sinus under ether inhalation at 30, 60 
and 120 min of glucose administered and glucose 




Induction of diabetes mellitus: 
Diabetes mellitus was induced in overnight fasted adult 
Wister strain albino rats weighing (170±5) g by single 
intraperitoneal injection of freshly prepared STZ at 
dose of 40 mg/kg bw in o.1M citrate buffer (pH=4.5). 
After seven days of STZ administration, blood glucose 
level was determined. Rats with blood glucose level 
above 200 mg/dl were considered diabetic and induced 
in the study. 
Experimental design: 
In the experiment a total of 36 rats (6 normal; 30 STZ 
diabetic surviving rats) were used. The rats were 
divided into six groups of six rats each. 
Group I: Normal control rats; Group II: Diabetic 
control rats; Group III: Diabetic rats treated with SC 
methanol extract at dose of 50 mg/kg bw; Group IV: 
Diabetic rats treated with SC methanol extract at dose 
of 100 mg/kg bw; Group V: Diabetic rats treated with 
SC methanol extract at dose of 200 mg/kg bw; Group 
VI: Diabetic rats treated with Glibenclamide at dose of 
600 μg/kg bw. The extract was dissolved in 2% tween 
80 solutions and administered orally in Group III, 
Group IV and Group V for two weeks. 
At the end of the study, the animals were euthanized 
between 0900-1100 h to minimize diurenal variation. 
Fasting blood glucose level was estimated by glucose 
oxidase-peroxidase method. The assay of insulin in the 
plasma of normal and diabetic rats was performed by 
enzyme-linked immunosorbent assay (ELISA) method. 
The glycogen level of liver and skeletal muscles was 
measured by anthrone method
12
. Glycosylated 
hemoglobin was estimated by the method of Sudhakar 
and Pattabiraman, 1981
13
. Lipid profile [total 
cholesterol, high density lipoprotein (HDL), cholesterol 
and triglyceride] levels in serum were determined 
according to the instructions of the manufacturer 
(Merck, Mumbai, India). Serum glutamic oxaloacetic 
transaminase (SGOT), serum glutamic-pyruvic 
transaminase (SGPT) and alkaline phosphatase (ALP) 





After blood sampling for the biochemical analysis, the 
animals were scarified, quickly dissected. Small slices 
of pancreases were taken and fixed in 10% formalin. 
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The specimens were dehydrated in ascending grades of 
ethanol. Cleared in xylene and embedded in paraffin 
wax. Sections of 6 μm in thickness were prepared and 





One-way ANOVA and Students t-test (SPSS program; 
version 11.5) were carried out to compare the data with 
the level of significance set at P≤0.05. 
RESULTS: 
Phytochemical analysis of SC methanol extract 
revealed the presence of Carbohydrate, Proteins, 
Sterols, Saponin, Coumarins, Lipid and flavonoids. 
The simple quantitative analysis of the extract was 
based on the intensity of colour change. 
Acute toxicity studies showed the non-toxic nature of 
the SC methanol extract. There was no lethality or any 
toxic reactions found at any of the doses selected until 
the end of the study period. In OGTT, SC methanol 
extract, from 30 min onwards showed significant 
reduction in plasma glucose levels (Table 1). 
Table 2 showed the changes in body weight of 
experimental rats at zero and final day of treatment. 
Significant decrease in body weight of diabetic control 
rats were observed when compared with normal control 
rats. However, significant increase in body weight was 
observed in SC methanol extract treated groups in dose 
dependent manner when compared with diabetic 
control rats.  
Inductions of diabetes in the experimental rats were 
confirmed by the presence of a high fasting blood 
glucose level. The effect of the SC methanol extract on 
the fasting blood glucose level normal and STZ 
induced diabetic animals were presented in table 3. At 
the end of 15
th
 day study SC methanol extract at 200 
mg/kg bw treated group reduced the fasting glucose 
level significantly (46.32%) when compared with 
diabetic control. 
Tables 4 and 5 showed the effect of SC methanol 
extract on serum insulin, glycosylated hemoglobin and 
liver and muscle glycogen content. Administration of 
SC methanol extract to diabetic rats for 15 days 
significantly increased the levels of serum insulin, liver 
glycogen content, muscle glycogen and significant 
decrease was observed in glycosylated hemoglobin 
when compared with diabetic control. 
Table6 showed increased level of total cholesterol, 
triglycerides and decreased level of HDL-cholesterol in 
diabetic rats compared to normal control. 
Administration of SC methanol extract for 15 days 
significantly reduced the total cholesterol, triglycerides 
levels and significantly increased the HDL-cholesterol 
level when compared with diabetic rats. 
The Table 7 showed the effect of administration SC 
methanol extract on serum marker enzymes. The 
concentration of SGOT, SGPT and ALP was increased 
in diabetes condition when compared with normal 
control. Administration of SC methanol extract and 
glibenclamide was found to keep the levels near to 
normal values. 
 




Treatment Blood glucose (mg/dL) 
0 min 30 min 60 min 120 min 
I Control + 2g/kg bw glucose 67.65±2.41 146.04±1.42** 132.59±1.29 122.68±1.88 
II SC 50mg/kgbw + 2g/kg bw glucose 65.97±1.28 133.79±0.84** 117.54±1.09** 102.16±1.88** 
III SC 100mg/kgbw + 2g/kg bw glucose 64.79±1.27 127.01±1.17** 111.56±1.09** 95.34±0.86** 
IV SC 200mg/kgbw + 2g/kg bw glucose 65.14±1.18 122.63±1.56** 101.66±0.90** 75.83±1.76** 
V Glibenclamide 600μg/kg bw + 2g/kg 
bw 
65.82±1.27 122.46±1.05** 112.68±1.22** 79.15±1.12** 
* Values deviate significantly from diabetic control; ** Values deviate very significantly (P≤ 0.05) when compared with diabetic 
control values. 
Table 2: Effect of oral administration of SC methanol extract on body weight in STZ induced diabetic rats 




Treatment Body weight (g) 
0 day (g) 15
th
 day (g) 
I Normal control 161.93±4.42 167.59±0.29 
II Diabetic control 167.04±6.84 138.54±1.09 
III Diabetic+ SC (50mg/kgbw) 166.01±2.17 171.56±2.09** 
IV Diabetic+ SC (100mg/kgbw) 148.63±2.56 164.66±3.90* 
V Diabetic+ SC (200mg/kgbw) 149.46±0.85 166.68±1.22** 
IV Diabetic+ Glibenclamide (600μg/kg bw) 158.46±1.75 175.68±2.22** 
* Values deviate significantly from diabetic control; ** Values deviate very significantly from diabetic control group (P≤ 0.05). 
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Table 3: Effect of oral administration of SC methanol extract on plasma glucose levels in STZ induced diabetic 




Treatment  Plasma glucose levels (mg/dL) 
0 day (g) 7
th
 day (g) 15
th
 day (g) 
I Normal control  74.93±1.42 74.93±1.42 75.59±1.29 
II Diabetic control 211.04±3.84 234.04±2.84 248.54±2.09 
III Diabetic+ SC (50mg/kgbw) 207.01±1.17 186.01±2.17 166.56±2.09** 
IV Diabetic+ SC (100mg/kgbw) 209.63±1.56 166.63±1.56 145.66±2.90** 
V Diabetic+ SC (200mg/kgbw) 210.46±1.85 157.46±0.85 114.68±1.22** 
IV Diabetic+ Glibenclamide (600μg/kg bw) 205.46±1.75 155.46±0.75 102.68±1.22** 
** Values deviate very significantly (P≤ 0.05) when compared with diabetic control values. 
 
Table 4: Effect of oral administration of SC methanol extract on plasma insulin levels in STZ induced diabetic 




Treatment Plasma Insulin (μU/mL) 
Zero day Final day 
I Normal control  128.93±0.42 131.59±1.29 
II Diabetic control 48.04±0.84 55.54±1.09 
III Diabetic+ SC (50mg/kgbw) 47.01±1.17 71.56±2.09** 
IV Diabetic+ SC (100mg/kgbw) 50.63±1.56 86.66±1.90* 
V Diabetic+ SC (200mg/kgbw) 51.46±1.85 114.68±1.22** 
IV Diabetic+ Glibenclamide (600μg/kg bw) 50.46±1.75 115.68±0.22** 
* Values deviate significantly from diabetic control; ** Values deviate very significantly (P≤ 0.05) when compared with diabetic 
control values. 
 
Table 5: Effect of oral administration of SC methanol extract on glycosylated hemoglobin, liver glycogen and 








(mg/g wet tissue) 
Muscle glycogen 
(mg/g wet tissue) 
I Normal control 4.00±0.13 54.05±0.93 7.53±0.14 
II Diabetic control 8.25±0.53 17.93±0.37 2.57±0.16 
III Diabetic+ SC (50mg/kgbw) 6.81±0.15* 23.23±1.27 3.39±0.13 
IV Diabetic+ SC (100mg/kgbw) 5.29±0.35* 29.53±0.45** 5.79±0.08** 
V Diabetic+ SC (200mg/kgbw) 4.79±0.27** 38.85±0.63** 7.47±0.17** 
IV Diabetic+ Glibenclamide (600μg/kg bw) 4.33±0.25** 47.17±0.65** 8.49±0.19** 
* Values deviate significantly from diabetic control; ** Values deviate very significantly (P≤ 0.05) when compared with diabetic 
control values. 
 
Table 6: Effect of oral administration of SC methanol extract on lipid profile in STZ induced diabetic rats 








I Normal control 54.93±2.42 45.93±2.42 72.59±2.29 
II Diabetic control 116.04±3.84 134.04±6.84 28.54±1.09 
III Diabetic+ SC (50mg/kgbw) 107.01±2.17* 96.01±3.17** 71.56±3.09** 
IV Diabetic+ SC (100mg/kgbw) 98.63±1.56** 91.63±1.56** 74.66±2.90** 
V Diabetic+ SC (200mg/kgbw) 94.46±1.85** 79.46±5.85** 75.68±1.22** 
IV Diabetic+ Glibenclamide (600μg/kg bw) 93.46±2.75** 111.46±1.75** 75.68±1.22** 
* Values deviate significantly from diabetic control; ** values deviate very significantly (P≤ 0.05) when compared with diabetic 
control values. 
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Table 7: Effect of oral administration of SC methanol extract on serum marker enzymes in STZ induced 




Treatment Serum marker enzymes (μ/L) 
SGOT SGPT ALP 
I Normal control 62.93±0.42 67.93±1.42 122.59±1.29 
II Diabetic control 153.04±2.84 156.04±1.84 243.54±1.09 
III Diabetic+ SC (50mg/kgbw) 123.01±1.17** 118.01±1.17** 171.56±1.09** 
IV Diabetic+ SC (100mg/kgbw) 95.63±0.56** 93.63±1.56** 138.66±0.90** 
V Diabetic+ SC (200mg/kgbw) 66.46±1.85** 75.46±2.85** 125.68±1.22** 
IV Diabetic+ Glibenclamide (600μg/kg 
bw) 
64.46±1.75** 66.46±1.75** 125.68±2.22** 
** Values deviate very significantly (P≤0.05) when compared with diabetic control values. 
 
DISCUSSION: 
The present study for the first time reports the 
antidiabetic and hypolipidemic effect of SC methanol 
extract in STZ induced diabetic rats. STZ in one of the 
most commonly used substances to induce diabetes in 
rats. This toxin causes the death of pancreatic β-cell by 
alkylation of DNA resulting in reduced synthesis and 
release of insulin. Furthermore, it has been shown to be 
involved in the fragmentation of DNA by means of 
production of reactive oxygen species
16, 17
. 
Induction of diabetes by STZ leads to loss of body 
weight due to the increased muscle wasting and loss of 
tissue proteins
18
. Administration of SC methanol extract 
for 15 days significantly increased the body weight 
when compared with diabetic control in dose dependent 
manner. When SC methanol extract was administered to 
glucose loaded normal rats fasted for 18 h, 
hypoglycemia was observed after 30 min. The decline 
in blood sugar level reached its maximum at 2 h. The 
observed significant increase in the level of blood 
glucose and significant decrease in the level of plasma 
insulin in diabetic rats could be due to the destruction of 
pancreatic β - cells by STZ19. Oral capacity of SC 
methanol extract to decrease the elevated blood sugar to 
normal glycemic level is an essential trigger for the 
liver to revert to its normal homeostasis during 
experimental diabetes. The possible mechanism by 
which SC methanol extract bring about its 
hypoglycemic action in diabetic rats may be improving 
glycemic control mechanism and insulin secretion from 
remnant pancreatic beta cells in diabetic rats
20
, as it is 
evidenced by the significant increase in the level of 
insulin in treated rats by SC methanol extract (200 
mg/kg bw). 
Phytochemical investigation of SC methanol extract 
reveals the presences of Carbohydrate, Proteins, Sterols, 
Saponin, Coumarins, Lipid and flavonoids. These 
principles are known to be bioactive for the 
management of diabetes. It is well known that certain 
flavonoids exhibit hypoglycemic activity and pancreas 
beta cell regeneration ability. Sterols have also shown to 
decrease blood sugar in experimental animal models
21
. 
Thus, the significant antidiabetic effect of aqueous SC 
extract may be due to the presence of more than one 
antihyperglycemic principle and their synergistic 
properties. 
Insulin is the main regulator of glycogenesis in muscle 
and liver. The decrease of liver glycogen level observed 
in this study may be due to lack of insulin in diabetic 
condition or oxidative stress which may inactivate the 
glycogen synthetase
22
. The marked reduction in liver 
and muscle glycogen level is observed (15 days) in 
streptozotocin induced diabetic animals. Treatment with 
SC methanol extract remarkably increased the glycogen 
level in liver and muscle. In the view of glycogen level, 
there may be three possible ways of antidiabetic action; 
one possible way may be increased insulin level by 
preventing the inactivation of the glycogen synthetase 
and by synthesize the glycogen synthatase
23
. The typical 
characteristics of diabetes is the increase of serum 
glycated protein such as glycated hemoglobin (HbA1C), 
which is a parameter for glycemic control where 
glucose or other reducing sugars react with the amino 
residues of proteins to form Amadori products such as 
glycated hemoglobin
24
. Animals treated with SC 
methanol extract significantly decreased the 
glycosylated hemoglobin level which could be due to an 
improvement in insulin secretion from the remnant 
pancreatic beta cells in diabetic rats
25
. 
Since lipid abnormalities accompanying with premature 
atherosclerosis is the major cause of cardiovascular 
diseases in diabetic patients, therefore ideal treatment 
for diabetes, in addition to glycemic control, should 
have a favorable effect on lipid profile. Cardiovascular 
diseases are listed as the cause of death in 65% people 
suffering from diabetes
26-31
. From this point of view, it 
is encouraging that the 15 day treatment of SC methanol 
extract brought down the elevated level of lipid profile 
such as total cholesterol, triglycerides to near normal 
level. There was increase in HDL-cholesterol also, 
which was desirable feature. 
HDL-cholesterol also, which was desirable feature. 
Liver is the vital organ of metabolism, detoxification, 
storage and excretion of xenobiotics and their 
metabolites. SGOT, SGPT and ALP are reliable 
markers of liver function. The liver was necrotized in 
STZ-induced diabetic rats. Therefore an increase in the 
activities of SGOT, SGPT and ALP in plasma might be 
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mainly due to the leakage of these enzymes from the 
liver cytosol into the blood stream which gives an 
indication of the hepatotoxic effect of STZ 
32
. 
Treatment of the diabetic rats with the SC methanol 
extract caused reduction in the activity of these 
enzymes in plasma compared to the diabetic control 
group and consequently alleviated liver damage caused 
by STZ-induced diabetes. These results are in 
agreement with those obtained by Eliza et al
33
. 
Histopathology studies also supported our findings. 
STZ was suspected to destroy pancreas partially. 
Diabetic rats showed reduced islet cells, which were 
restored to near normal upon treatment with the SC 
methanol extract. No such changes were found in the 
normal rats. 
The findings of this study indicate that consumption of 
SC methanol extract exerts significant antidiabetic and 
hypolipidemic effect in STZ-induced diabetic rats. 
Histopathological studies of the pancreas of SC 
methanol extract treated diabetic rats show evidence of 
signs of regeneration of β-cells. Longer duration studies 
of S. Colais and its isolated compounds on chronic 
models are necessary to elucidate the exact mechanism 
of action so as to develop it as a potent antidiabetic 
drug. 
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